De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator On-Demand Webinar De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator Watch the on-demand presentation covering how the DIDB® Concomitant Meds Navigator empowers clinical development teams…CertaraAugust 5, 2025
Model-based meta-analysis (MBMA) at GSK: Real-world impact on strategy and trials Blog Model-based meta-analysis (MBMA) at GSK: Real-world impact on strategy and trials GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…CertaraJuly 31, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.CertaraJuly 29, 2025
Three Approaches to AI Adoption in Regulatory Writing On-Demand Webinar Three Approaches to AI Adoption in Regulatory Writing Certara experts discuss AI adoption in medical writing: learn practical models, GenAI & SCA integration,…CertaraJuly 23, 2025
How to Create a Data Validation Plan in Clinical Trials Guide How to Create a Data Validation Plan in Clinical Trials Download our guide to creating a data validation plan in clinical trials, the ultimate blueprint…CertaraJuly 21, 2025
Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation On-Demand Webinar Needle in the Haystack: The Role of Data Fabrics in Successful AI Implementation CertaraJuly 18, 2025
Pirana Tips and Tricks – Report Object Generation in Pirana Webinar Pirana Tips and Tricks – Report Object Generation in Pirana CertaraJuly 1, 2025
The reference-scaled average bioequivalence (RSABE) approach Blog The reference-scaled average bioequivalence (RSABE) approach We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…CertaraJuly 1, 2025
5 clinical development challenges model-based meta-analysis (MBMA) helps address Blog 5 clinical development challenges model-based meta-analysis (MBMA) helps address June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…CertaraJune 30, 2025
Maintain & adapt pharma market access digital tools using feedback Blog Maintain & adapt pharma market access digital tools using feedback Maintain the credibility of your pharma market access digital tools through continuous updates based on…CertaraJune 30, 2025